NCT07281365

Brief Summary

The goal of this study is to develop and test an outpatient intervention for preadolescents (ages 7-12) with self-injurious thoughts and behaviors (SITBs). The main questions it aims to answer are:

  1. 1.Does the newer intervention lead to better engagement of families in treatment compared to treatment as usual (TAU)?
  2. 2.Is the new intervention feasible, acceptable, and appropriate?
  3. 3.Does the new intervention lead to more improvements in SITBs, mental health symptoms, and treatment targets compared to TAU?
  4. 4.Complete an initial baseline assessment to determine eligibility and assess SITBs, mental health symptoms, executive functioning, and emotion regulation
  5. 5.Participate in a \~weekly, outpatient intervention lasting around 3-4 months
  6. 6.Complete additional assessments at mid-treatment, post-treatment, and 3-month follow-up
  7. 7.Participate in an interview sharing their perceptions of the intervention

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
24mo left

Started May 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026May 2028

First Submitted

Initial submission to the registry

December 1, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

December 1, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

PreadolescentsChildrenSelf-InjurySuicidal ideation and behaviorRandomized controlled trialFeasibility

Outcome Measures

Primary Outcomes (7)

  • Treatment Engagement

    Number of treatment sessions completed at post-treatment

    From enrollment to post-treatment at 12 weeks

  • Feasibility of Retention

    % participants completing treatment (benchmark =≥ 80% participants considered treatment completers)

    From enrollment to the end of treatment at 12 weeks

  • Feasibility of recruitment

    % recruitment targets met (benchmark = 52 preadolescents randomized to receive treatment)

    Calculated at enrollment

  • Feasibility of Measurement

    % participants at each timepoint completing measures (target = ≥ 80% at each timepoint).

    From enrollment to follow-up at 24 weeks

  • Perceived acceptability of intervention

    The Acceptability of Intervention Measure (AIM; Weiner et al., 2017) will be completed by preadolescents, caregivers, and therapists. The AIM is a 4-item measure assessing the extent to which stakeholders believe an intervention to be acceptable. Items are rated from 1 ("completely disagree") to 5 ("completely agree"), with higher scores indicating greater acceptability. The acceptability benchmark for all reporters is set at a mean score of 4 or greater.

    From enrollment to the end of treatment at 12 weeks

  • Perceived Feasibility of Intervention

    The Feasibility of Intervention Measure (FIM; Weiner et al., 2017) will be completed by preadolescents, caregivers, and therapists. The FIM is a 4-item measures assessing the extent to which stakeholders believe an intervention to be feasible. Items are rated from 1 ("completely disagree") to 5 ("completely agree"), with higher scores indicating greater feasibility. The feasibility benchmark for all reporters is set at a mean score of 4 or greater.

    From enrollment to the end of treatment at 12 weeks

  • Perceived Appropriateness of Intervention

    The Intervention Appropriateness Measure (IAM; Weiner et al., 2017) will be completed by preadolescents, caregivers, and therapists. The IAM is a 4-item measure assessing the extent to which stakeholders believe an intervention or to be appropriate. Items are rated from 1 ("completely disagree") to 5 ("completely agree"), with higher scores indicating greater appropriateness. The appropriateness benchmark for all reporters is set at a mean score of 4 or greater.

    From enrollment to the end of treatment at 12 weeks

Secondary Outcomes (3)

  • Suicidal Ideation Intensity

    From enrollment to 3-month follow-up at 24 weeks

  • Readmission/Admission Rates

    From enrollment to 3-month follow-up at 24 weeks

  • Non-Suicidal Self-Injury

    From enrollment to 3-month follow-up at 24 weeks

Other Outcomes (8)

  • Anxiety Symptoms

    From enrollment to 3-month follow-up at 24 weeks

  • Depression Symptoms

    From enrollment to 3-month follow-up at 24 weeks

  • Disruptive Behavior Symptoms

    From enrollment to 3-month follow-up at 24 weeks

  • +5 more other outcomes

Study Arms (2)

Preadolescent SITB Intervention

EXPERIMENTAL

Experimental intervention for preadolescent SITBs targeting executive functioning, emotion regulation, and other SITB risk factors

Behavioral: Preadolescent SITB Intervention

Treatment as Usual (TAU)

ACTIVE COMPARATOR

Treatment as Usual provided by outpatient mental health therapist

Behavioral: Treatment as usual (TAU)

Interventions

Typical interventions Outpatient therapist would provide to a preadolescent with SITBs, based on their clinical judgement

Treatment as Usual (TAU)

Experimental intervention developed with end-users and experts to target emotion regulation, executive functioning, and other risk factors for SITBs in preadolescents

Preadolescent SITB Intervention

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • between the ages of 7-12
  • at least one caregiver/legal guardian able to participate (more permitted)
  • experienced at least one episode of SITBs within the last month
  • ability to attend weekly sessions in-person or via telehealth
  • ability to attend baseline and 12-week assessments in-person.
  • estimated verbal IQ of 70 or greater

You may not qualify if:

  • symptoms interfering with ability to participate in assessments/therapy (i.e., psychosis)
  • estimated verbal IQ\<70 or previous diagnosis of intellectual development disorder
  • requiring inpatient psychiatric stabilization or high-intensity intervention to prevent hospitalization
  • active substance use
  • ward of the state

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Self-Injurious BehaviorSuicidal IdeationBehaviorEmotional Regulation

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral SymptomsSuicideSelf-ControlSocial Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2025

First Posted

December 15, 2025

Study Start

May 1, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

December 15, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

IPD from the randomized controlled trial will be shared with the NIMH National Data Archive.

Shared Documents
STUDY PROTOCOL, SAP, ICF